Shaping the future of diabetes care - Roche

More documents

Recommendations

Info

Disetronic – who they are • A leading global supplier of medical devices and systems for the administration of liquid medication for ambulatory therapies • The world’s No. 2 in insulin pumps for the treatment of diabetes… • … and the largest independent manufacturer of injection pens for various therapies r 26
Diabetes is not curable, but it is manageable r • Detect diabetes at an early stage and treat it correctly – Type I (10 %) – insulin therapy – Type II (90 %) – insulin, oral, exercise, diet etc... • Blood glucose levels for people with diabetes are generally too high and subject to extreme fluctuations • Insulin is lacking or completely unavailable – or it is available but not sufficiently effective • Insulin therapy: – measure blood glucose levels regularly – determine insulin requirement – administer insulin 27
Page 1 and 2: Shaping the future of diabetes care
Page 3 and 4: The idea Roche Diagnostics, the wor
Page 5 and 6: Strategic rationale Shaping the fut
Page 7 and 8: Diabetes: a problem of epidemic pro
Page 9 and 10: Glucose monitoring and insulin deli
Page 11 and 12: Roche adding marketing and sales mu
Page 13 and 14: Entry into insulin pump market Grow
Page 15 and 16: Disetronic, the world’s No. 2 in
Page 17 and 18: Business model with two elements br
Page 19 and 20: Proposed transaction structure r Ef
Page 21 and 22: Transaction multiples based upon th
Page 23 and 24: Public tender offer on Disetronic s
Page 25: About Roche Diabetes Care • Pione

Shaping the future of diabetes care - Roche

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?